| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 06/30/2004 | CN1509291A Oxazolo-and-furopyrimidines and their use in medicaments against tumors |
| 06/30/2004 | CN1509290A Process for synthesis of derivatives of 2,30dihydro-1,4-dioxino-[2,3-f]quinoline |
| 06/30/2004 | CN1509183A Use of proteasome inhibitors to treat dry eye disorders |
| 06/30/2004 | CN1509140A Pyridinyl fused bicyclic amide as fungicides |
| 06/30/2004 | CN1508137A 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor |
| 06/30/2004 | CN1155578C Production of cyclic acid |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756378 VLA-4 inhibitor compounds |
| 06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
| 06/24/2004 | WO2004052893A2 Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052864A1 Pyrazole and imidazole compounds and uses thereof |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004017922A3 Keto cannabinoids with therapeutic indications |
| 06/24/2004 | WO2003105724A3 Novel maxi-k channel blockers, methods of use and process for making the same |
| 06/24/2004 | WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2002092594A8 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 06/24/2004 | US20040122230 Opiate analogs selective for the delta -opioid receptor |
| 06/24/2004 | US20040122074 1-[5-(4-chloro-phenyl)-1-(2-chloro-phenyl)-4-methyl-1H-pyrazol-3-yl]-2-piperidin-1-yl-ethanone,e.g. as antagonist or inverse agonists; nicotine partial agonist; an opioid antagonist; a dopaminergic agent; an attention deficit disorder agent |
| 06/24/2004 | US20040122073 E.g., 1-[[7-(aminoiminomethyl)-2-naphthalenyl]methyl]-2,5-dioxo-4-phenyl-3-(phenylmethyl)-4-imidazolidineacetamide; enzme enzyme inhibitors of the blood Factor VIIa complex; myocardial infarction; antiischemic agents; brain disorders , |
| 06/24/2004 | US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 06/24/2004 | US20040122034 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-1yl)acetamide |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | US20040121997 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/24/2004 | US20040121911 Ketol fatty acid derivative and plant growth regulators |
| 06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
| 06/24/2004 | CA2509242A1 Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | CA2505887A1 Pyrazole and imidazole compounds and uses thereof |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1430903A1 Use of proteasome inhibitors for the treatment of viral infections |
| 06/23/2004 | EP1430059A1 Pharmaceutically acceptable salts of 20(s)-camptothecins |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | CN1507446A Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 06/23/2004 | CN1507445A Chromenylmethyl pyrimidinediamines as antibacterial agents |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1154646C Benzisozazoles and phenones as alpha antagonist |
| 06/23/2004 | CN1154634C 2-phenyl-substituted heterocyclic 1,3-keonols as herbicides and pesticides |
| 06/22/2004 | US6753430 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 06/22/2004 | US6753429 1,4-disubstituted benzenes as insecticides |
| 06/22/2004 | US6753342 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 06/22/2004 | US6753331 Heterocyclic derivatives which inhibit factor Xa |
| 06/17/2004 | WO2004050652A1 Novel azole derivatives |
| 06/17/2004 | WO2004050629A2 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 06/17/2004 | WO2004050623A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same |
| 06/17/2004 | WO2004050035A2 Benzimidazoles and analogs thereof as antivirals |
| 06/17/2004 | WO2004013282A3 Bis (amino acid) molecular scaffolds |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116469 Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists |
| 06/17/2004 | US20040116461 Immunomodulatory compounds |
| 06/17/2004 | US20040116457 Agents for improving excretory potency of urinary bladder |
| 06/17/2004 | US20040116456 Remedies for psychoneurosis |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116417 Thiohydantoins and use thereof for treating diabetes |
| 06/17/2004 | US20040116410 Diazepinones as antiviral agents |
| 06/17/2004 | US20040116406 for the treatment of disorders of the central nervous system such as cerebral, central nervous or psychiatric symptoms, defunctionalization manifestations or disorders which occur as a result of unintentional or intentional intake of psychotropic |
| 06/17/2004 | US20040116404 Sulphones which modulate the action of gamma secretase |
| 06/17/2004 | US20040116328 Condensed imidazole derivatives |
| 06/17/2004 | DE19742593B4 Neuer farbbildender Farbstoffvorläufer, Zusammensetzung, die denselben enthält und farbbildendes wärmeempfindliches Aufzeichnungsmaterial New color-forming dye precursor composition comprising the same and color-forming heat-sensitive recording material |
| 06/17/2004 | DE10256405A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | DE10247233A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | CA2508311A1 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 06/17/2004 | CA2507875A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | CA2507742A1 Novel azole derivatives |
| 06/16/2004 | EP1428824A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 06/16/2004 | EP1427732A1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 06/16/2004 | EP1427728A1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 06/16/2004 | EP1427727A1 Compounds which inhibit the release of inflammatory cytokines |
| 06/16/2004 | EP1427722A2 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 06/16/2004 | EP1427706A1 Substituted pyrazolo compounds for the treatment of inflammation |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/16/2004 | EP1427407A2 Fatty amine drug conjugates |
| 06/16/2004 | EP1427287A1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds |
| 06/16/2004 | EP1341763B1 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization |
| 06/16/2004 | EP1119570B1 Tricyclic delta3-piperidines as pharmaceuticals |
| 06/16/2004 | CN1505626A Novel benzylpiperidine compound |
| 06/16/2004 | CN1505613A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1505516A Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances |
| 06/16/2004 | CN1505514A Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 06/16/2004 | CN1153771C Benzofuran-[3,4-f] quinoline derivatives, combination containing the same and application thereof |
| 06/15/2004 | US6750357 Rhodamine-based fluorophores useful as labeling reagents |
| 06/15/2004 | US6750346 Chromenes as terminal end groups |
| 06/15/2004 | US6750233 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750223 To inhibit the growth of a variety of tumor/cancer cells, especially leukemia, colon, melanoma, and breast cancer cells |
| 06/15/2004 | US6750214 Quinoline and quinazoline compounds useful in therapy |
| 06/15/2004 | CA2313302C New metalloprotease inhibitors, the process for preparing them and the pharmaceutical compounds containing them |
| 06/15/2004 | CA2153195C New benzopyran derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 06/10/2004 | WO2004048378A1 Pyrazoloquinolines with immunomodulating activity |
| 06/10/2004 | WO2004048332A1 Isoindoline derivative |
| 06/10/2004 | WO2004047837A2 Beta-blockers having antioxidant and nitric oxide-donor activity |
| 06/10/2004 | WO2004047755A2 Fused bicyclic nitrogen-containing heterocycles |
| 06/10/2004 | WO2004032845A3 R-nsaid esters and their use |
| 06/10/2004 | WO2004028445A3 Processes for preparing 1,3-dioxolane nucleosides |
| 06/10/2004 | WO2003072027A3 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 06/10/2004 | US20040110945 Very Late Antigen (Vla-4); such as 4-((4S)-fluoro-1-(2-phenylamino-6-benzoxazolylacetyl)-(2S)-pyrrolidinylmethoxy)benzoic acid; for treatment of inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, and diabetes |